Walgreens Boots Alliance Inc. has taken a major step forward in its bid to go private after it announced that at the Company's Special Meeting of Shareholders, WBA shareholders had approved the previously announced acquisition of the company by entities affiliated with Sycamore Partners Management.
Walgreens Boots Alliance shareholders Friday approved private equity firm Sycamore Partners' $10 billion buyout offer for the iconic drugstore chain.
News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership.
| - Industry | - Sector | Timothy C. Wentworth CEO | NASDAQ (NGS) Exchange | 931427108 CUSIP |
| US Country | 193,000 Employees | 18 Nov 2024 Last Dividend | 16 Feb 1999 Last Split | 1 Jul 1985 IPO Date |
Walgreens Boots Alliance, Inc. stands prominently as a leading figure in the health and beauty retail sector, guided by its pharmacy-led approach. The organization splits its operations into two fundamental segments: the United States and International. Within the United States, it boasts a broad network of retail drugstores under the Walgreens and Duane Reade brands, focusing on selling prescription drugs along with a diverse assortment of retail products. This includes items across health, wellness, beauty, personal care, consumables, and general merchandise. Further extending its healthcare services, it provides specialized central specialty pharmacy and mail services. Internationally, Walgreens Boots Alliance, Inc. continues its retail prowess, offering prescription drugs, health and wellness products, beauty, personal care items, and consumer goods through its pharmacy-led health and beauty retail stores and optical practices. This international presence is bolstered by a robust online presence and a mobile application. The company also has an arm in pharmaceutical wholesaling and distribution in Germany, showcasing its extensive reach across key global markets. Founded in 1901 and headquartered in Deerfield, Illinois, Walgreens Boots Alliance, Inc. has cemented its position as a cornerstone in the global retail pharmacy landscape.
In the United States, Walgreens Boots Alliance operates 8,965 retail stores under the Walgreens and Duane Reade banners. These stores offer a wide range of prescription drugs alongside an extensive variety of retail products. This includes health and wellness products, beauty and personal care items, consumables, and general merchandise, catering to the diverse needs of their customers.
This service showcases the company's commitment to healthcare, offering specialized pharmacy services that cater to specific medical conditions, alongside convenient mail services for prescription drugs. This ensures that medications are delivered safely and efficiently to patients' homes, enhancing the accessibility and convenience of healthcare services.
Globally, Walgreens Boots Alliance expands its healthcare and retail offerings through pharmacy-led health and beauty retail stores and optical practices. Operating under various brands such as Boots, Benavides, and Ahumada, the company serves customers in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Through these outlets, it sells prescription drugs and a wide array of health and wellness, beauty, personal care, and other consumer products. Additionally, 548 optical practices, including 160 on a franchise basis, offer professional eye care and optometry services.
To complement its physical store network, Walgreens Boots Alliance offers an online shopping experience through boots.com and an integrated mobile application. This digital approach enables customers to shop for health and wellness products, beauty items, personal care goods, and other consumer products conveniently from their homes, making health and beauty retail more accessible to a wider audience.
In addition to retail, Walgreens Boots Alliance engages in the pharmaceutical wholesaling and distribution sector in Germany. This part of the business underscores the company's involvement in the broader pharmaceutical supply chain, ensuring the efficient and reliable distribution of prescription drugs and healthcare products to various healthcare providers and pharmacies.